On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to pooled ZIKV testing. Additionally, on July 5th Grifols received licensure for their NAT ZIKV test for both individual and pooled donations.
Check out the Communication page for the complete details on the NAT ZIKV test or by clicking the link: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...